Author: Williamson, E. D.
Title: Vaccines for emerging pathogens: from research to the clinic Document date: 2019_4_16
ID: jri02z0a_2
Snippet: Understanding the interaction of the host with a viral pathogen to expedite vaccine development is a theme taken up in the review contributed by Sharpe et al. [2] . Specifically, they address the targeting of the human leucocyte antigen (HLA)-E molecule, a major histocompatibility complex (MHC)1b molecule, by viral vectors to induce non-classical CD8 + T cell immunity and to inhibit natural killer (NK) cell activity. However, the authors acknowle.....
Document: Understanding the interaction of the host with a viral pathogen to expedite vaccine development is a theme taken up in the review contributed by Sharpe et al. [2] . Specifically, they address the targeting of the human leucocyte antigen (HLA)-E molecule, a major histocompatibility complex (MHC)1b molecule, by viral vectors to induce non-classical CD8 + T cell immunity and to inhibit natural killer (NK) cell activity. However, the authors acknowledge that there remain some questions of safety with this HLA-E targeting approach to vaccination; for example, the existence of self-peptides which are able to up-regulate HLA-E activity. The preclinical data, for
Search related documents:
Co phrase search for related documents- cell activity and host interaction: 1, 2, 3, 4, 5, 6, 7, 8
- cell activity and major histocompatibility complex: 1, 2, 3, 4, 5, 6
- cell activity and natural killer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cell activity and natural killer NK cell activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- cell activity and NK cell activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cell immunity and histocompatibility complex: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- cell immunity and host interaction: 1, 2, 3, 4, 5
- cell immunity and major histocompatibility complex: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- cell immunity and natural killer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- cell immunity and NK cell activity: 1, 2
- cell immunity and self peptide: 1, 2
- histocompatibility complex and host interaction: 1, 2, 3
- histocompatibility complex and major histocompatibility complex: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- histocompatibility complex and molecule major histocompatibility complex: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- histocompatibility complex and natural killer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- histocompatibility complex and natural killer NK cell activity: 1
- histocompatibility complex and NK cell activity: 1, 2
- histocompatibility complex and self peptide: 1, 2
- host interaction and major histocompatibility complex: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date